Transgene (France) Analysis

Transgene Stock Analysis Notes

The book value of the company was at this time reported as 0.55. The company recorded a loss per share of 0.23. Transgene SA had not issued any dividends in recent years. The entity had 40:39 split on the 18th of June 2019. Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company was founded in 1979 and is headquartered in Illkirch-Graffenstaden, France. TRANSGENE operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 132 people. To find out more about Transgene SA contact Hedi Brahim at 33 3 88 27 91 00 or learn more at https://www.transgene.fr.

Transgene SA Investment Alerts

Transgene Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 205.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Transgene's market, we take the total number of its shares issued and multiply it by Transgene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Transgene Profitablity

The company has Profit Margin (PM) of (1.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.39.

Technical Drivers

As of the 5th of February, Transgene has the Coefficient Of Variation of (586.57), risk adjusted performance of (0.14), and Variance of 7.81. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Transgene SA, as well as the relationship between them.

Transgene SA Price Movement Analysis

Transgene Outstanding Bonds

Transgene Predictive Daily Indicators

Transgene Forecast Models

Transgene's time-series forecasting models are one of many Transgene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Transgene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Transgene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Transgene shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Transgene. By using and applying Transgene Stock analysis, traders can create a robust methodology for identifying Transgene entry and exit points for their positions.

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.